Old Well Partners’s Ambrx Biopharma Inc AMAM Stock Holding History

Old Well Partners’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,400	Closed	-$205K	–	44
2023 Q4	$205K	Buy	+14,400	New	+$164K	0.18%	36

Old Well Partners's AMAM Position: Q1 2024 in Review

Old Well Partners sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 14,400 shares — an estimated $205K sold.

Old Well Partners first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $205K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Old Well Partners reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Old Well Partners sold 14,400 Ambrx Biopharma Inc shares in Q1 2024, an estimated $205K.
Old Well Partners first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
Old Well Partners's Ambrx Biopharma Inc position peaked at $205K in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Old Well Partners's 13F filing for Q1 2024, filed 15 May 2024.